The Brighterside of News on MSN
Scientists map a road to fairer, more inclusive drug development
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
A generation ago, writing a piece like this about using artificial intelligence to develop genome-editing medicines would have sounded like a Star Trek plotline. But both fields have matured to the ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...
As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies can reach the patients who need them most or remain costly, complex ...
Join the ELRIG conference to hear from experts on cell and gene therapy. Discover advancements shaping the future of medicine.
This story was originally published by ProPublica. ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive its biggest stories as soon as they’re published. Vincent ...
The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...
An estimated 3 million Americans have an inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback